Potential use of melatonergic drugs in analgesia: Mechanisms of action

Autores
Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; Brown, Gregory M.; Cardinali, Daniel Pedro
Año de publicación
2010
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures.
Fil: Srinivasan, Venkataramanujam. Shri Sathya Sai Medical College and Research Institute; India
Fil: Pandi Perumal, Seithikurippu R.. Somnogen; Estados Unidos
Fil: Spence, David Warren. Canadian Sleep Society; Canadá
Fil: Moscovitch, Adam. Canadian Sleep Society; Canadá
Fil: Trakht, Ilya. Columbia University College of Physicians and Surgeons; Estados Unidos
Fil: Brown, Gregory M.. University of Toronto; Canadá
Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Materia
ALLODYNIA
ANALGESIA
MELATONIN
MELATONIN ANALOGS
MELATONIN RECEPTORS
NEUROPATHIC PAIN
NOCICEPTION
OPIOID RECEPTORS
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/98829

id CONICETDig_dfa038812e15a684342c3fb2ff1b0d86
oai_identifier_str oai:ri.conicet.gov.ar:11336/98829
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Potential use of melatonergic drugs in analgesia: Mechanisms of actionSrinivasan, VenkataramanujamPandi Perumal, Seithikurippu R.Spence, David WarrenMoscovitch, AdamTrakht, IlyaBrown, Gregory M.Cardinali, Daniel PedroALLODYNIAANALGESIAMELATONINMELATONIN ANALOGSMELATONIN RECEPTORSNEUROPATHIC PAINNOCICEPTIONOPIOID RECEPTORShttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures.Fil: Srinivasan, Venkataramanujam. Shri Sathya Sai Medical College and Research Institute; IndiaFil: Pandi Perumal, Seithikurippu R.. Somnogen; Estados UnidosFil: Spence, David Warren. Canadian Sleep Society; CanadáFil: Moscovitch, Adam. Canadian Sleep Society; CanadáFil: Trakht, Ilya. Columbia University College of Physicians and Surgeons; Estados UnidosFil: Brown, Gregory M.. University of Toronto; CanadáFil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaPergamon-Elsevier Science Ltd2010-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/98829Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; et al.; Potential use of melatonergic drugs in analgesia: Mechanisms of action; Pergamon-Elsevier Science Ltd; Brain Research Bulletin; 81; 4-5; 3-2010; 362-3710361-9230CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0361923009003670info:eu-repo/semantics/altIdentifier/doi/10.1016/j.brainresbull.2009.12.001info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:48:34Zoai:ri.conicet.gov.ar:11336/98829instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:48:35.263CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Potential use of melatonergic drugs in analgesia: Mechanisms of action
title Potential use of melatonergic drugs in analgesia: Mechanisms of action
spellingShingle Potential use of melatonergic drugs in analgesia: Mechanisms of action
Srinivasan, Venkataramanujam
ALLODYNIA
ANALGESIA
MELATONIN
MELATONIN ANALOGS
MELATONIN RECEPTORS
NEUROPATHIC PAIN
NOCICEPTION
OPIOID RECEPTORS
title_short Potential use of melatonergic drugs in analgesia: Mechanisms of action
title_full Potential use of melatonergic drugs in analgesia: Mechanisms of action
title_fullStr Potential use of melatonergic drugs in analgesia: Mechanisms of action
title_full_unstemmed Potential use of melatonergic drugs in analgesia: Mechanisms of action
title_sort Potential use of melatonergic drugs in analgesia: Mechanisms of action
dc.creator.none.fl_str_mv Srinivasan, Venkataramanujam
Pandi Perumal, Seithikurippu R.
Spence, David Warren
Moscovitch, Adam
Trakht, Ilya
Brown, Gregory M.
Cardinali, Daniel Pedro
author Srinivasan, Venkataramanujam
author_facet Srinivasan, Venkataramanujam
Pandi Perumal, Seithikurippu R.
Spence, David Warren
Moscovitch, Adam
Trakht, Ilya
Brown, Gregory M.
Cardinali, Daniel Pedro
author_role author
author2 Pandi Perumal, Seithikurippu R.
Spence, David Warren
Moscovitch, Adam
Trakht, Ilya
Brown, Gregory M.
Cardinali, Daniel Pedro
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv ALLODYNIA
ANALGESIA
MELATONIN
MELATONIN ANALOGS
MELATONIN RECEPTORS
NEUROPATHIC PAIN
NOCICEPTION
OPIOID RECEPTORS
topic ALLODYNIA
ANALGESIA
MELATONIN
MELATONIN ANALOGS
MELATONIN RECEPTORS
NEUROPATHIC PAIN
NOCICEPTION
OPIOID RECEPTORS
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures.
Fil: Srinivasan, Venkataramanujam. Shri Sathya Sai Medical College and Research Institute; India
Fil: Pandi Perumal, Seithikurippu R.. Somnogen; Estados Unidos
Fil: Spence, David Warren. Canadian Sleep Society; Canadá
Fil: Moscovitch, Adam. Canadian Sleep Society; Canadá
Fil: Trakht, Ilya. Columbia University College of Physicians and Surgeons; Estados Unidos
Fil: Brown, Gregory M.. University of Toronto; Canadá
Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
description Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures.
publishDate 2010
dc.date.none.fl_str_mv 2010-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/98829
Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; et al.; Potential use of melatonergic drugs in analgesia: Mechanisms of action; Pergamon-Elsevier Science Ltd; Brain Research Bulletin; 81; 4-5; 3-2010; 362-371
0361-9230
CONICET Digital
CONICET
url http://hdl.handle.net/11336/98829
identifier_str_mv Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; et al.; Potential use of melatonergic drugs in analgesia: Mechanisms of action; Pergamon-Elsevier Science Ltd; Brain Research Bulletin; 81; 4-5; 3-2010; 362-371
0361-9230
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0361923009003670
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.brainresbull.2009.12.001
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Pergamon-Elsevier Science Ltd
publisher.none.fl_str_mv Pergamon-Elsevier Science Ltd
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846083006603722752
score 13.22299